- Home
- PLSE vs CINT Comparison
PLSE vs CINT Comparison
Compare PLSE & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- CINT
- Stock Information
- Founded
- PLSE 2014
- CINT 1995
- Country
- PLSE United States
- CINT Brazil
- Employees
- PLSE N/A
- CINT N/A
- Industry
- PLSE Medical/Dental Instruments
- CINT EDP Services
- Sector
- PLSE Health Care
- CINT Technology
- Exchange
- PLSE Nasdaq
- CINT Nasdaq
- Market Cap
- PLSE 1.1B
- CINT 695.8M
- IPO Year
- PLSE 2016
- CINT 2021
- Fundamental
- Price
- PLSE $16.30
- CINT $5.58
- Analyst Decision
- PLSE Buy
- CINT Strong Buy
- Analyst Count
- PLSE 1
- CINT 4
- Target Price
- PLSE $22.00
- CINT $7.20
- AVG Volume (30 Days)
- PLSE 179.1K
- CINT 233.9K
- Earning Date
- PLSE 10-29-2025
- CINT 11-13-2025
- Dividend Yield
- PLSE N/A
- CINT N/A
- EPS Growth
- PLSE N/A
- CINT 34.66
- EPS
- PLSE N/A
- CINT 0.25
- Revenue
- PLSE N/A
- CINT $452,826,000.00
- Revenue This Year
- PLSE N/A
- CINT $11.21
- Revenue Next Year
- PLSE $700.00
- CINT $13.48
- P/E Ratio
- PLSE N/A
- CINT $22.91
- Revenue Growth
- PLSE N/A
- CINT 1.02
- 52 Week Low
- PLSE $13.77
- CINT $4.42
- 52 Week High
- PLSE $25.00
- CINT $8.00
- Technical
- Relative Strength Index (RSI)
- PLSE 56.58
- CINT 59.77
- Support Level
- PLSE $13.83
- CINT $5.00
- Resistance Level
- PLSE $16.80
- CINT $5.88
- Average True Range (ATR)
- PLSE 0.73
- CINT 0.21
- MACD
- PLSE 0.10
- CINT 0.05
- Stochastic Oscillator
- PLSE 83.00
- CINT 65.91
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About CINT CI&T Inc
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.